Literature DB >> 1716842

A novel source of mast cells: the human placenta.

W M Purcell1, T H Hanahoe.   

Abstract

The presence of moderate amounts of histamine in the human placenta was confirmed (0.72 +/- 0.10 microgram/g wet weight), and the hitherto unknown storage site of this biogenic amine was elucidated. Mast cells were identified by their characteristic morphology, staining reactions and secretory activity measured in terms of histamine release. Human placental tissue contains 7.6 x 10(5) mast cells/g wet weight, identified by staining with toluidine blue or alcian blue, and these cells were positive for chloro-acetate-esterase. Light microscope studies of placental tissue stained with HRP-conjugated anti-human IgE demonstrated cells with a typical 'halo' effect indicating cell-bound IgE, and electron microscopy revealed cells containing membrane-bound electron dense granules. A single mast cell was calculated to contain approximately 1 pg of histamine. Enzymatic digestion of placental tissue with collagenase (1.5 mg/ml) yielded viable cell suspension. containing mast cells in a purity of 0.6% which exhibited a low spontaneous output of histamine (12%). Placental mast cells released histamine in a concentration dependent manner upon challenge with anti-human IgE and the calcium ionophore A23187. Also, unlike other human mast cells so far studied. with the exception of skin, those dispersed from human placenta were responsive to the polybasic secretagogue compound 48/80. These findings represent a novel source of human mast cells and, since placentas are readily available in quantity, such tissue is proposed as an ideal source of mast cells for biochemical and pharmacological use.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1716842     DOI: 10.1007/bf01993113

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  6 in total

1.  Action of adrenaline, acetylcholine and other substances on nerve-free vessels (human placenta).

Authors:  U S V Euler
Journal:  J Physiol       Date:  1938-07-14       Impact factor: 5.182

2.  Observations on histamine and histaminolysis in pregnancy.

Authors:  F WICKSELL
Journal:  Acta Physiol Scand       Date:  1949-04-14

3.  Detection of histamine in human placental perfusate and the effect of histamine releasers.

Authors:  F W Kohler; R F Gautieri; D E Mann
Journal:  Res Commun Chem Pathol Pharmacol       Date:  1988-08

4.  Determination of histaminase activity in histologic samples and its quantitative distribution in intact human placenta and uterus.

Authors:  R E Gunther; D Glick
Journal:  J Histochem Cytochem       Date:  1967-08       Impact factor: 2.479

5.  A modified fluorometric procedure for tissue histamine and its distribution in various animals.

Authors:  A H Anton; D F Sayre
Journal:  J Pharmacol Exp Ther       Date:  1969-04       Impact factor: 4.030

6.  Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils, and colon in response to IgE-dependent and nonimmunologic stimuli.

Authors:  M A Lowman; P H Rees; R C Benyon; M K Church
Journal:  J Allergy Clin Immunol       Date:  1988-03       Impact factor: 10.793

  6 in total
  8 in total

Review 1.  Mast cells in neuroimmune function: neurotoxicological and neuropharmacological perspectives.

Authors:  W M Purcell; C K Atterwill
Journal:  Neurochem Res       Date:  1995-05       Impact factor: 3.996

2.  Effect of the H1-antagonist bromadryl on mast cells in pregnant rats ex vivo.

Authors:  K Drábiková; J Pecivová; E Ujházy; R Nosál
Journal:  Inflamm Res       Date:  1995-04       Impact factor: 4.575

3.  Human tissue mast cells are an inducible reservoir of persistent HIV infection.

Authors:  J Bruce Sundstrom; Jane E Ellis; Gregory A Hair; Arnold S Kirshenbaum; Dean D Metcalfe; Hong Yi; Adriana C Cardona; Michael K Lindsay; Aftab A Ansari
Journal:  Blood       Date:  2007-03-09       Impact factor: 22.113

4.  IgE is expressed on, but not produced by, fetal cells in the human placenta irrespective of maternal atopy.

Authors:  E Sverremark Ekstrom; C Nilsson; U Holmlund; I van der Ploeg; B Sandstedt; G Lilja; A Scheynius
Journal:  Clin Exp Immunol       Date:  2002-02       Impact factor: 4.330

Review 5.  Mast Cell Activation Syndrome in COVID-19 and Female Reproductive Function: Theoretical Background vs. Accumulating Clinical Evidence.

Authors:  Dariusz Szukiewicz; Piotr Wojdasiewicz; Mateusz Watroba; Grzegorz Szewczyk
Journal:  J Immunol Res       Date:  2022-06-22       Impact factor: 4.493

6.  Mast cells and histamine: do they influence placental vascular network and development in preeclampsia?

Authors:  Grzegorz Szewczyk; Michał Pyzlak; Jakub Klimkiewicz; Wacław Smiertka; Magdalena Miedzińska-Maciejewska; Dariusz Szukiewicz
Journal:  Mediators Inflamm       Date:  2012-06-19       Impact factor: 4.711

7.  Transfer of regulatory T cells into abortion-prone mice promotes the expansion of uterine mast cells and normalizes early pregnancy angiogenesis.

Authors:  Katja Woidacki; Nicole Meyer; Anne Schumacher; Alexandra Goldschmidt; Marcus Maurer; Ana Claudia Zenclussen
Journal:  Sci Rep       Date:  2015-09-10       Impact factor: 4.379

Review 8.  Genitourinary mast cells and survival.

Authors:  Theoharis C Theoharides; Julia M Stewart
Journal:  Transl Androl Urol       Date:  2015-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.